Literature DB >> 34035484

Amygdala dynorphin/κ opioid receptor system modulates depressive-like behavior in mice following chronic social defeat stress.

Gui-Ying Zan1,2, Xiang Sun3, Yu-Jun Wang2, Rui Liu1, Chen-Yao Wang2,4, Wei-Jia Du1, Liu-Bin Guo2, Jing-Rui Chai2, Qing-Lin Li5, Zhi-Qiang Liu6, Jing-Gen Liu2.   

Abstract

Major depression disorder is a severe and recurrent neuropsychological disorder characterized by lowered mood and social activity and cognitive impairment. Owing to unclear molecular mechanisms of depression, limited interventions are available in clinic. In this study we investigated the role of dynorphin/κ opioid receptor system in the development of depression. Mice were subjected to chronic social defeat stress for 14 days. Chronic social defeat stress induced significant social avoidance in mice characterized by decreased time duration in the interaction zone and increased time duration in the corner zone. Pre-administration of a κ opioid receptor antagonist norBNI (10 mg/kg, i.p.) could prevent the development of social avoidance induced by chronic social defeat stress. Social avoidance was not observed in κ opioid receptor knockout mice subjected to chronic social defeat stress. We further revealed that social defeat stress activated c-fos and ERK signaling in the amygdala without affecting the NAc, hippocampus and hypothalamus, and ERK activation was blocked by systemic injection of norBNI. Finally, the expression of dynorphin A, the endogenous ligand of κ opioid receptor, was significantly increased in the amygdala following social defeat stress; microinjection of norBNI into the amygdala prevented the development of depressive-like behaviors caused by social defeat stress. The present study demonstrates that upregulated dynorphin/κ opioid receptor system in the amygdala leads to the emergence of depression following chronic social defeat stress, and sheds light on κ opioid receptor antagonists as potential therapeutic agents for the prevention and treatment of depression following chronic stress.
© 2021. The Author(s), under exclusive licence to CPS and SIMM.

Entities:  

Keywords:  ERK; amygdala; c-fos; depression; dynorphin; norBNI; social defeat stress; κ opioid receptor

Mesh:

Substances:

Year:  2021        PMID: 34035484      PMCID: PMC8888759          DOI: 10.1038/s41401-021-00677-6

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  72 in total

Review 1.  Depression.

Authors:  Gin S Malhi; J John Mann
Journal:  Lancet       Date:  2018-11-02       Impact factor: 79.321

Review 2.  Role of GABA in anxiety and depression.

Authors:  Allan V Kalueff; David J Nutt
Journal:  Depress Anxiety       Date:  2007       Impact factor: 6.505

3.  Adolescent forced swim stress increases social anxiety-like behaviors and alters kappa opioid receptor function in the basolateral amygdala of male rats.

Authors:  E I Varlinskaya; J M Johnson; K R Przybysz; T Deak; M R Diaz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-11-07       Impact factor: 5.067

Review 4.  Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.

Authors:  Marc Fakhoury
Journal:  Mol Neurobiol       Date:  2015-04-01       Impact factor: 5.590

5.  Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.

Authors:  Yu-Jun Wang; Khampaseuth Rasakham; Peng Huang; Darina Chudnovskaya; Alan Cowan; Lee-Yuan Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  2011-08-12       Impact factor: 4.030

6.  Pathway- and Cell-Specific Kappa-Opioid Receptor Modulation of Excitation-Inhibition Balance Differentially Gates D1 and D2 Accumbens Neuron Activity.

Authors:  Hugo A Tejeda; Jocelyn Wu; Alana R Kornspun; Marco Pignatelli; Vadim Kashtelyan; Michael J Krashes; Brad B Lowell; William A Carlezon; Antonello Bonci
Journal:  Neuron       Date:  2017-01-04       Impact factor: 17.173

Review 7.  Neurobiology of depression.

Authors:  Eric J Nestler; Michel Barrot; Ralph J DiLeone; Amelia J Eisch; Stephen J Gold; Lisa M Monteggia
Journal:  Neuron       Date:  2002-03-28       Impact factor: 17.173

Review 8.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

9.  Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.

Authors:  Jonathan M Ehrich; Daniel I Messinger; Cerise R Knakal; Jamie R Kuhar; Selena S Schattauer; Michael R Bruchas; Larry S Zweifel; Brigitte L Kieffer; Paul E M Phillips; Charles Chavkin
Journal:  J Neurosci       Date:  2015-09-16       Impact factor: 6.167

10.  Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes.

Authors:  E Hu; E Mueller; S Oliviero; V E Papaioannou; R Johnson; B M Spiegelman
Journal:  EMBO J       Date:  1994-07-01       Impact factor: 11.598

View more
  1 in total

1.  Dynorphin participates in interaction between depression and non-erosive reflux disease.

Authors:  Yi Wang; Bingduo Zhou; Shengquan Fang; Shengliang Zhu; Tingting Xu; Makan Dilikumaer; Guanwu Li
Journal:  Esophagus       Date:  2022-10-16       Impact factor: 3.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.